Meet Dr. Stacey Stein
July 30, 2021Meet Dr. Stacey Stein
.
Information
Dr. Stacey Stein cares for patients with GI cancers, with a focus on hepatobiliary cancers. She discusses the role of clinical trials, and recent advances that have been made in liver cancer.
ID6851
To CiteDCA Citation Guide
- 00:00Hi, my name is Stacy Stein.
- 00:03I'm an associate professor
- 00:05of medicine at Yale.
- 00:06I've been here since 2010 and I focus
- 00:09in GI cancers specifically with
- 00:11a focus in hepatobiliary cancers.
- 00:13I think I always knew I
- 00:15wanted to go into medicine,
- 00:17but in thinking about when did
- 00:20I first really think about
- 00:22oncology when I was in college?
- 00:24One of my grandmothers was diagnosed
- 00:27with pancreatic cancer and it was
- 00:29a very tough year for our family.
- 00:32Uhm, and I think it really connected
- 00:35me to really appreciating how the
- 00:38science and new discoveries could
- 00:41help these types of patients.
- 00:44I think that's when the seed was
- 00:46kind of first planted for me.
- 00:48It's a tough position to be in
- 00:50when there's a question of a cancer
- 00:53diagnosis and people are waiting for a plan.
- 00:56We try to put people at ease,
- 00:59answer all of their questions,
- 01:00come up with a plan together.
- 01:02Really think about all of the options,
- 01:05but just to know that the team
- 01:07is here to take care of you and
- 01:10you know we really want to know
- 01:12what's important to you,
- 01:14what questions you have and what we
- 01:16can do to make things easier for you.
- 01:19I think it's important to
- 01:21have your support team there,
- 01:23and cancer care is really a
- 01:25full team that's involved, so.
- 01:27It's often the patient and
- 01:29their team at home,
- 01:30and then the team that you have here at
- 01:34the hospital and we all work together.
- 01:37We have many studies open for
- 01:39patients with GI cancers,
- 01:41and I've been mostly focused in
- 01:43developing new clinical trials
- 01:45and opening studies for patients
- 01:47with hepatobiliary cancers,
- 01:48and that has been very rewarding and
- 01:51so just in the last couple of years,
- 01:55there's been multiple new therapies
- 01:57for liver cancer.
- 01:58We had participated in one of the
- 02:01groundbreaking phase one studies
- 02:03of looking at the combination
- 02:06of atezolizumab and bevacizumab
- 02:08for liver cancer patients,
- 02:10and just this past year that drug
- 02:13combination was approved and it's
- 02:15just been really rewarding to see
- 02:18the treatment options changing
- 02:20and improving for our patients.